Full Text View
Tabular View
No Study Results Posted
Related Studies
Salvage mFOLFOX in BTC After Failure of Gemcitabine
The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2010 by Chung-Ang University.
Recruitment status was  Recruiting
Study NCT01127555   Information provided by Chung-Ang University

First Received on May 5, 2010.   Last Updated on June 22, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Unresectable Biliary Tract Cancer
Additional conditions recognized in this trial
Biliary Tract Neoplasms
More general conditions related to this trial
Biliary Tract Diseases
Digestive System Diseases
Digestive System Neoplasms
Neoplasms
Neoplasms by Site
Additional drug interventions recognized in this trial
Fluorouracil
Gemcitabine
Leucovorin
Levoleucovorin
Oxaliplatin
More general drug interventions related to this trial
Anti-Infective Agents
Antidotes
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antiviral Agents
Enzyme Inhibitors
Growth Substances
Immunologic Factors
Immunosuppressive Agents
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Radiation-Sensitizing Agents
Therapeutic Uses
Vitamin B Complex
Vitamins
Sponsors listed in this trial
Chung-Ang University
Gyeongsang National University Hospital
Dong-A University Hospital
Samsung Medical Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services